|
Radioactive Drug Research Committee |
|
As a subcommittee of the Radiation Safety and Surveillance Committee, the major responsibility of this committee is to provide authorization, surveillance, and oversight to the use of radioactive drugs in human subjects.
Read the complete committee charge.
|
|
Ex officio |
Departments |
|
Pichika, Rama |
Radiopharmacist |
|
Singleton, Corey |
Radiation Safety Officer |
|
Smith, Ken |
Research Safety Manager |
|
Appointed |
Departments |
|
Belezzuoli, Ernest (Chair) |
Radiology/Nuclear Medicine faculty representative |
|
Hoh, Carl |
Nuclear Medicine faculty representative |
|
Nelson, T. R. |
Radiology faculty representative |
|
Vera, David |
Radiopharmacist representative |
Charge to committee:
This committee is to provide authorization, surveillance, and oversight to the use of radioactive drugs in human subjects. The committee is a subcommittee of, and reports to the Radiation Safety and Surveillance Committee, but operates under approval of the Food and Drug Administration (FDA) according to Part 361 of Title 21 of the Code of Federal Regulations.
Meetings will be held as necessary to review and conduct the business of the committee, with at least 1 meeting per calendar quarter.
A quorum of this committee, consisting of at least 4 members, including the Radiation Safety Officer, is necessary to conduct business.
The chair of this committee shall also serve as an ex officio member of the Radiation Safety and Surveillance Committee.
Changes or updates? Contact Rachel Jensen, (858) 534-7951.
| 
At Your Service Online
